Back to search

McMaster University

Optimization and Validation of LC-MS/MS Biochemical Genetics Assays for Monitoring Patients with Inherited Metabolic Disorders

Abstract

dc:description.abstract

Inherited metabolic disorders require accurate biochemical testing for diagnosis, treatment monitoring, and prevention of metabolic crises. Despite advances in clinical laboratory medicine, biochemical monitoring remains limited by lengthy analysis times, reduced analytical specificity, and gaps in specialized testing. To address these challenges, this thesis focused on improving biochemical genetics testing by optimizing, validating, and clinically applying liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays for amino acid and ammonia scavenging drug analysis. A clinically applicable LC-MS/MS amino acid assay using pre-column derivatization was optimized and validated for plasma and urine analysis, enabling quantification of 45 amino acids at three times the speed of prior methods. This method met Clinical Laboratory Standards Institute performance requirements for linearity, precision, sensitivity, and bias. This work was extended through method verification and reference interval implementation to support clinical laboratory adoption. The method was also applied to cerebrospinal fluid to characterize amino acid distributions and explore differences between non-disordered individuals and patients with heterogeneous neurological disorders, identifying several amino acids with potential biomarker relevance. An additional LC-MS/MS assay was developed, verified, and clinically applied for therapeutic monitoring of ammonia scavenging drugs and metabolites in patients with urea cycle disorders. This work addressed a gap in specialized biochemical testing in Canada and enabled exploratory assessment of drug-metabolite relationships in patient samples, with potential implications for therapeutic monitoring and dose optimization. Collectively, this thesis demonstrates the expanding clinical utility of LC-MS/MS in biochemical genetics across multiple matrices and applications, providing validated analytical tools and exploratory findings that support improved monitoring of inherited metabolic disorders.

Degree

thesis:*
Department dc:contributor.department
Medical Sciences
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Theron, Kiara
Advisor dc:contributor.advisor
  • Potter, Murray

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivs 2.5 Canada

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Theron, Kiara. Optimization and Validation of LC-MS/MS Biochemical Genetics Assays for Monitoring Patients with Inherited Metabolic Disorders. 2026. https://hdl.handle.net/11375/33308